Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer
(in billion U.S. dollars)
Characteristic
Private Insurance
Medicare Part D
Managed Medicaid
Limited PBM
2,668
2,484
570
Average PBM
2,199
2,048
470
Best practice PBM
1,730
1,611
369
The chart is not accessible to screen readers. Please switch to the table view to access the data.
According to the source, for the period from 2023 to 2032, projected 10-year drug expenditures under best practice use of Pharmacy Benefit Management would total over 3.7 trillion U.S. dollars, with the highest amount associated with private insurance at around 1.73 trillion dollars. This statistic shows the projected 10 year drug expenditure in the U.S. from 2023 to 2032 under limited, average, and best practice PBM use, by payer.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Visante, & Pharmaceutical Care Management Association. (January 31, 2023). Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/
Visante, und Pharmaceutical Care Management Association. "Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars)." Chart. January 31, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/
Visante, Pharmaceutical Care Management Association. (2023). Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/
Visante, and Pharmaceutical Care Management Association. "Projected Drug Expenditures under Three Levels of Pharmacy Benefit Management (Pbm) Use in The U.S. for The Period 2023-2032, by Payer (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Jan 2023, /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/
Visante & Pharmaceutical Care Management Association, Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/ (last visited July 25, 2026)
Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars) [Graph], Visante, & Pharmaceutical Care Management Association, January 31, 2023. [Online]. Available: /statistics/1172957/pbm-projected-10-year-expenditure-by-scenario-and-payer/
